Guide for patients & caregivers

High Lipase or Amylase on a GLP-1 Medicine: Is It Pancreatitis?

High lipase or amylase on semaglutide, liraglutide or tirzepatide explained: pancreatitis warning signs first, what raised enzymes alone mean and what to ask.

By SameCase EditorialUpdated 6 min read

Prepared with AI assistance and checked against the cited sources. No independent clinician review has been completed. How we prepare articles

What does high lipase or amylase mean on a GLP-1 medicine?

A raised lipase or amylase result on a GLP-1 medicine such as semaglutide, liraglutide or tirzepatide can mean pancreatitis, but it does not always. In clinical trials, average levels of both enzymes went up on some of these medicines, and the US prescribing information for tirzepatide says the meaning of the rise is unknown when there are no other signs of pancreatitis. Symptoms come first: severe, lasting tummy pain needs urgent assessment.

This guide is for adults who take a GLP-1 receptor agonist or the dual GIP/GLP-1 medicine tirzepatide and have been told their lipase or amylase is high. It explains what clinicians usually weigh up. It cannot tell you whether you have pancreatitis or what to do with your medicine. For the result itself, see our guides on elevated lipase and high amylase.

Pancreatitis symptoms that need urgent care

The UK medicines regulator, the MHRA, strengthened its warning about acute pancreatitis with these medicines in January 2026. It noted rare reports of necrotising (tissue-destroying) and fatal cases. Its advice for patients is to "seek urgent medical attention if you experience severe, persistent abdominal pain, that may radiate to your back and may be accompanied by nausea and vomiting". Outside the UK, use your local emergency number. Take your medicines, or a list of them, and say that you take a GLP-1 medicine. The MHRA points out that private prescriptions may not appear in your medical record.

The NHS acute pancreatitis page says to call 999 or go to A&E if you get sudden, severe tummy pain and any of the following:

  • the pain is spreading to your back
  • bloating that does not go away or keeps coming back
  • a fast heartbeat or difficulty breathing
  • skin around the belly button, waist or upper outer thigh that looks blue or bruised, which can be harder to see on black or brown skin

Why can it be hard to spot pancreatitis on these medicines?

Nausea, vomiting and tummy discomfort are common side effects of GLP-1 medicines. The MHRA says early pancreatitis can be hard to recognise because these symptoms may be put down to ordinary side effects or an infection.

The NHS describes pancreatitis pain as often starting suddenly and not going away, and as severe, sharp or knife-like. It may be in the upper tummy, on one side or across the whole tummy, may spread to the sides and back, and may feel worse after eating, moving or lying down and ease when leaning forward. Pain like this is different from mild queasiness after an injection and should not be waited out.

Can GLP-1 medicines raise lipase without pancreatitis?

Yes, according to the prescribing information. In placebo-controlled trials of injected semaglutide, the average rise from baseline was 13% for amylase and 22% for lipase. These changes were not seen with placebo. For tirzepatide, pooled trials showed average rises of 31% to 42% in lipase and 33% to 38% in pancreatic amylase.

These are averages across groups of people. They do not tell you what your own number means. The tirzepatide prescribing information says the clinical significance of the rise is unknown "in the absence of other signs and symptoms of pancreatitis". A clinician will therefore look at the size of the rise, how you feel and how the result compares with earlier tests.

Confirmed acute pancreatitis did happen in the trials, but it was uncommon. The MHRA describes it as a recognised side effect whose overall frequency remains uncommon, with rare severe cases.

What else can raise lipase or amylase?

A raised enzyme on a GLP-1 medicine is not automatically caused by the medicine. MedlinePlus lists other causes of higher-than-normal lipase, including gallbladder disease, chronic kidney disease, peptic ulcer, blocked bowel, diabetes, salivary gland problems and alcohol use disorder. It also notes that many medicines can affect lipase levels.

The NHS lists gallstones and drinking a lot of alcohol as the most common causes of acute pancreatitis. The NHS tirzepatide page also lists gallstones as a possible serious side effect. This is why clinicians ask about alcohol, gallbladder symptoms, other medicines and previous results instead of looking at one enzyme alone.

What usually happens after a high result?

What happens next depends on symptoms. If you are unwell, the NHS says acute pancreatitis is usually diagnosed with blood tests and sometimes a CT scan, and needs hospital treatment straight away. If you feel well, the prescriber may compare the result with the lab's reference range and earlier tests, repeat it, or check other blood results. Reference ranges differ between laboratories, so the number needs reading against your own report.

Decisions about the medicine belong to the clinician. The MHRA tells healthcare professionals to stop the GLP-1 medicine immediately if pancreatitis is suspected and not to restart it if the diagnosis is confirmed. It also advises caution in people who have had pancreatitis before.

Should I stop my GLP-1 medicine if my lipase is high?

Do not stop or change a prescribed medicine without talking to the prescriber. The NHS pages for semaglutide and tirzepatide say to talk to your doctor if you want to stop, and not to stop suddenly, because in type 2 diabetes stopping could affect blood sugar.

If you have the urgent symptoms above, get emergency help first and tell the team about the medicine. If you feel well and only the blood result is high, contact the prescriber or the pharmacy that supplied the medicine and ask what they want you to do before your next dose. You can report a suspected side effect through the MHRA Yellow Card scheme in the UK, or through your local reporting system.

Questions to ask your clinician

Take the printed result with the reference range, the medicine name and any earlier enzyme results.

  • How high is my result compared with the lab's upper limit, and was it checked because of symptoms or as routine monitoring?
  • Do my symptoms and examination suggest pancreatitis, or is this a raised enzyme on its own?
  • Do I need a repeat test, other blood tests or a scan, and when?
  • Could gallstones, alcohol, kidney function or another medicine explain this?
  • What should I do about my next dose, and who do I contact if pain starts?
  • Which symptoms mean I should go straight to emergency care?

How SameCase can help you prepare

On SameCase, patients and verified doctors share de-identified cases. Reading how others described a raised lipase on a similar medicine, which tests followed and what their clinicians asked can help you write clearer questions before an appointment. Other people's cases cannot tell you whether you have pancreatitis or what to do with your medicine. Your own clinician's assessment comes first, and severe pain needs urgent care, not an online search.

Sources and further reading

For patients & caregivers

Share your case and learn from others

Learn from doctors and other people's cases to find a way forward with your health problem. New cases are public immediately. Don't add names or identifying details.

Keep learning